{"id":53604,"date":"2023-02-03T11:02:21","date_gmt":"2023-02-03T10:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/"},"modified":"2023-02-03T11:02:21","modified_gmt":"2023-02-03T10:02:21","slug":"2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/","title":{"rendered":"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644445\/global-trypanosomiasis-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=6rh853&amp;utm_campaign=1816711+-+2022+Trypanosomiasis+Clinical+Trial+Pipeline+Global+Overview%3A+Emerging+Therapies+for+Trypanosomiasis+in+Active+Clinical+Development+Stages&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Trypanosomiasis Clinical Trial Pipeline Highlights &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides the most up-to-date information on key pipeline products within the global Trypanosomiasis market. It covers emerging therapies for Trypanosomiasis in active clinical development stages including early and late stage clinical trials.\n<\/p>\n<p>\nThe pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n<p>\n<strong>Clinical Trial Stages:<\/strong>\n<\/p>\n<p>\nThe report provides Trypanosomiasis pipeline products by clinical trial stages including both early and late stage development &#8211; phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n<p>\n<strong>Drug Mechanism Classes:<\/strong>\n<\/p>\n<p>\nThe report provides Trypanosomiasis pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n<p>\n<strong>Company:<\/strong>\n<\/p>\n<p>\nThe report provides Trypanosomiasis pipeline products by the company.\n<\/p>\n<p>\n<strong>Short-term Launch Highlights:<\/strong>\n<\/p>\n<p>\nFind out which Trypanosomiasis pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n<p>\n<strong>SUMMARY:<\/strong>\n<\/p>\n<ul>\n<li>\nTrypanosomiasis phase 3 clinical trial pipeline products\n<\/li>\n<li>\nTrypanosomiasis phase 2 clinical trial pipeline products\n<\/li>\n<li>\nTrypanosomiasis phase 1 clinical trial pipeline products\n<\/li>\n<li>\nTrypanosomiasis preclinical research pipeline products\n<\/li>\n<li>\nTrypanosomiasis discovery stage pipeline products\n<\/li>\n<li>\nTrypanosomiasis pipeline products short-term launch highlights\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644445\/global-trypanosomiasis-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=6rh853&amp;utm_campaign=1816711+-+2022+Trypanosomiasis+Clinical+Trial+Pipeline+Global+Overview%3A+Emerging+Therapies+for+Trypanosomiasis+in+Active+Clinical+Development+Stages&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/lxdylr<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;&#x3a;&#x70;r&#x65;&#115;&#x73;&#64;&#x72;&#101;s&#x65;&#97;&#x72;&#99;&#x68;&#97;n&#x64;&#109;&#x61;&#114;&#x6b;&#101;t&#x73;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#x72;&#x63;h&#97;&#110;&#x64;&#x6d;a&#114;&#x6b;&#x65;t&#115;&#46;&#x63;&#x6f;m<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Trypanosomiasis Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Trypanosomiasis market. It covers emerging therapies for Trypanosomiasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53604","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Trypanosomiasis Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Trypanosomiasis market. It covers emerging therapies for Trypanosomiasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T10:02:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-02-03T10:02:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/\"},\"wordCount\":326,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005184\\\/en\\\/1704744\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/\",\"name\":\"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005184\\\/en\\\/1704744\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-02-03T10:02:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005184\\\/en\\\/1704744\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230203005184\\\/en\\\/1704744\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Trypanosomiasis Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Trypanosomiasis market. It covers emerging therapies for Trypanosomiasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-03T10:02:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages &#8211; ResearchAndMarkets.com","datePublished":"2023-02-03T10:02:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/"},"wordCount":326,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/","name":"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg","datePublished":"2023-02-03T10:02:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230203005184\/en\/1704744\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/2022-trypanosomiasis-clinical-trial-pipeline-global-overview-emerging-therapies-for-trypanosomiasis-in-active-clinical-development-stages-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"2022 Trypanosomiasis Clinical Trial Pipeline Global Overview: Emerging Therapies for Trypanosomiasis in Active Clinical Development Stages &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53604"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53604\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}